Akèy › Skleroderm Difize › Massachusetts › Boston
Etid klinik pou Skleroderm Difize nan Boston, MA
5 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Ap rekriteFaz 2
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Ap rekriteFaz 1
- Boston Medical Center, Boston
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Massachusetts General Hospital, Boston
- Boston University (BU), Boston
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
Ap rekriteVolontè an sante akeyi
- Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
- Brigham And Womens Hospital, Boston
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Ann Arbor, MI7 etid
- Chicago, IL7 etid
- Los Angeles, CA6 etid
- Durham, NC6 etid
- Houston, TX5 etid
- Baltimore, MD5 etid
- Philadelphia, PA4 etid
- Kansas City, KS4 etid
- New Orleans, LA4 etid
- Pittsburgh, PA4 etid
- Charlotte, NC3 etid
Lòt etid nan Boston
- Kansè nan tete110 etid
- Kansè Poumon ki pa ti selil89 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat60 etid
- Depresyon51 etid
- Kansè Endomèt50 etid
- Leksemi mieloïd egi45 etid
- Kansè pankreyas44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.